22.728 articles found

Focus on Parkinson's: causes, treatment and support.

Heisters D.

Br J Community Nurs · 2011-04-01

DOI: 10.12968/bjcn.2011.16.4.182PMID: 21471920

Daily motor performance after switching levodopa to melevodopa: an open-label on advanced Parkinson's disease with "delayed-on" and/or"wearing-off".

Bosco D, Plastino M, Bosco F, Fava A, Rotondo A.

Minerva Med · 2011-04-01

PMID: 21483399

Gene therapy for Parkinson's disease shows promise.

Björklund A, Björklund T.

Sci Transl Med · 2011-04-01

DOI: 10.1126/scitranslmed.3002430PMID: 21508307

Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study.

Keller GA, Czerniuk P, Bertuola R, Spatz JG, Assefi AR, Di Girolamo G.

Clin Ther · 2011-04-01

DOI: 10.1016/j.clinthera.2011.04.012PMID: 21635995

A novel protein degradation system in young-onset Parkinson's disease: mitophagy is a therapeutic target as a quality control for damaged mitochondria.

Hatano T.

Mov Disord · 2011-04-01

DOI: 10.1002/mds.23754PMID: 21671510

Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.

Gui ZH, Liu J, Wang Y, Ali U, Wang T, Chen L.

Chin J Physiol · 2011-04-01

DOI: 10.4077/cjp.2011.amm014PMID: 21789890

[Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease].

Krüger R, Weiss D.

MMW Fortschr Med · 2011-04-01

PMID: 21966866

Safety of rasagiline for the treatment of Parkinson's disease.

Perez-Lloret S, Rascol O.

Expert Opin Drug Saf · 2011-04-01

DOI: 10.1517/14740338.2011.573784PMID: 21453201

Treatment dilemma in comorbidity of schizophrenia and idiopathic Parkinson's disease.

Lan CC, Su TP, Chen YS, Bai YM.

Gen Hosp Psychiatry · 2011-04-01

DOI: 10.1016/j.genhosppsych.2011.02.006PMID: 21762841

Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.

Flood PM, Qian L, Peterson LJ, Zhang F, Shi JS, Gao HM, Hong JS.

Parkinsons Dis · 2011-03-30

DOI: 10.4061/2011/216298PMID: 21603248

Use of 14-3-3-Proteins in Treatment and Prevention of Neurodegeneration

YACOUBIAN TALENE ALENE, STANDAERT DAVID G.

· 2011-03-29

Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?

Carta AR, Pisanu A, Carboni E.

Parkinsons Dis · 2011-03-29

DOI: 10.4061/2011/689181PMID: 21603186